Suivre
Katie Jeffery
Katie Jeffery
Oxford University Hospital NHS Foundation Trust
Adresse e-mail validée de burcot.net
Titre
Citée par
Citée par
Année
Effect of dexamethasone in hospitalized patients with COVID-19–preliminary report
P Horby, WS Lim, J Emberson, M Mafham, J Bell, L Linsell, N Staplin, ...
MedRxiv, 2020.06. 22.20137273, 2020
11432*2020
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
RECOVERY Collaborative Group
Lancet (London, England) 397 (10285), 1637, 2021
15282021
Effect of hydroxychloroquine in hospitalized patients with Covid-19
RECOVERY Collaborative Group
New England Journal of Medicine 383 (21), 2030-2040, 2020
14572020
Antibody status and incidence of SARS-CoV-2 infection in health care workers
SF Lumley, D O’Donnell, NE Stoesser, PC Matthews, A Howarth, ...
New England Journal of Medicine 384 (6), 533-540, 2021
9712021
SARS-CoV-2 Omicron-B. 1.1. 529 leads to widespread escape from neutralizing antibody responses
W Dejnirattisai, J Huo, D Zhou, J Zahradník, P Supasa, C Liu, ...
Cell 185 (3), 467-484. e15, 2022
8932022
Lopinavir–ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
PW Horby, M Mafham, JL Bell, L Linsell, N Staplin, J Emberson, ...
The Lancet 396 (10259), 1345-1352, 2020
7912020
COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study
VJ Hall, S Foulkes, A Saei, N Andrews, B Oguti, A Charlett, E Wellington, ...
The Lancet 397 (10286), 1725-1735, 2021
7552021
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
RECOVERY Collaborative Group, PW Horby, M Mafham, L Peto, ...
Medrxiv, 2021.06. 15.21258542, 2021
748*2021
SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN)
VJ Hall, S Foulkes, A Charlett, A Atti, EJM Monk, R Simmons, E Wellington, ...
The Lancet 397 (10283), 1459-1469, 2021
6692021
Antibody escape of SARS-CoV-2 Omicron BA. 4 and BA. 5 from vaccine and BA. 1 serum
A Tuekprakhon, R Nutalai, A Dijokaite-Guraliuc, D Zhou, HM Ginn, ...
Cell 185 (14), 2422-2433. e13, 2022
5622022
Candida auris: a review of the literature
A Jeffery-Smith, SK Taori, S Schelenz, K Jeffery, EM Johnson, A Borman, ...
Clinical microbiology reviews 31 (1), 10.1128/cmr. 00029-17, 2018
5562018
HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy
KJM Jeffery, K Usuku, SE Hall, W Matsumoto, GP Taylor, J Procter, ...
Proceedings of the National Academy of Sciences 96 (7), 3848-3853, 1999
4931999
Association between administration of IL-6 antagonists and mortality among patients hospitalized for COVID-19: a meta-analysis
P Domingo, I Mur, GM Mateo, M del Mar Gutierrez, V Pomar, N de Benito, ...
Jama 326 (6), 499-518, 2021
4662021
Multilocus Sequence Typing of Clostridium difficile
D Griffiths, W Fawley, M Kachrimanidou, R Bowden, DW Crook, R Fung, ...
Journal of clinical microbiology 48 (3), 770-778, 2010
4612010
A Candida auris Outbreak and Its Control in an Intensive Care Setting
DW Eyre, AE Sheppard, H Madder, I Moir, R Moroney, TP Quan, ...
New England Journal of Medicine 379 (14), 1322-1331, 2018
3872018
Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison
M Ainsworth, M Andersson, K Auckland, JK Baillie, E Barnes, S Beer, ...
The Lancet Infectious Diseases 20 (12), 1390-1400, 2020
3162020
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): preliminary results of a randomised, controlled, open-label, platform trial
PW Horby, G Pessoa-Amorim, L Peto, CE Brightling, R Sarkar, K Thomas, ...
Medrxiv, 2021
2982021
Challenges for NHS hospitals during covid-19 epidemic
J Willan, AJ King, K Jeffery, N Bienz
BMJ 368, 2020
2932020
Differential occupational risks to healthcare workers from SARS-CoV-2 observed during a prospective observational study
DW Eyre, SF Lumley, D O'Donnell, M Campbell, E Sims, E Lawson, ...
elife 9, e60675, 2020
2702020
Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine
RP Payne, S Longet, JA Austin, DT Skelly, W Dejnirattisai, S Adele, ...
Cell 184 (23), 5699-5714. e11, 2021
2662021
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20